Jefferson M Jones1, Ruth A Shults2, Byron Robinson3, Kenneth K Komatsu4, Erin K Sauber-Schatz2. 1. Arizona Department of Health Services, 150 N. 18th Avenue, Suite 100, Phoenix, AZ 85007, United States; Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention (CDC), 1600 Clifton Road, Atlanta, GA 30329, United States; United States Public Health Service, 1600 Clifton Road, Atlanta, GA 30329, United States. Electronic address: ioe8@cdc.gov. 2. United States Public Health Service, 1600 Clifton Road, Atlanta, GA 30329, United States; Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC, 1600 Clifton Road, Atlanta, GA 30329, United States. 3. Division of Scientific Education and Professional Development, National Center for Surveillance, Epidemiology, and Laboratory Services, CDC, 1600 Clifton Road, Atlanta, GA 30329, United States. 4. Arizona Department of Health Services, 150 N. 18th Avenue, Suite 100, Phoenix, AZ 85007, United States.
Abstract
BACKGROUND: We examined marijuana and alcohol use trends among drivers aged ≥16 years evaluated at Level I trauma centers before and after Arizona legalized medical marijuana in April 2011. METHODS: We conducted interrupted time series (ITS) analysis of urine drug screens for marijuana metabolites and blood alcohol concentration (BAC) data from the 2008-2014 Arizona State Trauma Registry. RESULTS: Among 30,083 injured drivers, 14,710 had marijuana test results, and 2590 were positive for marijuana; of these, 1087 (42%) also tested positive for alcohol. Among 23,186 drivers with BAC results, 5266 exceeded the legal limit for their age. Compared with prelaw trends (models if law had not been enacted), postlaw models showed small but significant annual increases in the proportions of drivers testing positive for either substance. By the end of 2014, the proportion of drivers testing positive for marijuana was 9.6% versus a projected 5.6% if the law had not been enacted, and the proportion of drivers with illegal BACs was 15.7% versus a projected 8.2%. When ITS was restricted to only substance-tested drivers, no significant differences were detected. CONCLUSIONS: Despite the small annual postlaw increases in the proportion of marijuana-positive drivers compared with the prelaw trend, alcohol-impaired driving remains a more prevalent threat to road safety in Arizona. Published by Elsevier B.V.
BACKGROUND: We examined marijuana and alcohol use trends among drivers aged ≥16 years evaluated at Level I trauma centers before and after Arizona legalized medical marijuana in April 2011. METHODS: We conducted interrupted time series (ITS) analysis of urine drug screens for marijuana metabolites and blood alcohol concentration (BAC) data from the 2008-2014 Arizona State Trauma Registry. RESULTS: Among 30,083 injured drivers, 14,710 had marijuana test results, and 2590 were positive for marijuana; of these, 1087 (42%) also tested positive for alcohol. Among 23,186 drivers with BAC results, 5266 exceeded the legal limit for their age. Compared with prelaw trends (models if law had not been enacted), postlaw models showed small but significant annual increases in the proportions of drivers testing positive for either substance. By the end of 2014, the proportion of drivers testing positive for marijuana was 9.6% versus a projected 5.6% if the law had not been enacted, and the proportion of drivers with illegal BACs was 15.7% versus a projected 8.2%. When ITS was restricted to only substance-tested drivers, no significant differences were detected. CONCLUSIONS: Despite the small annual postlaw increases in the proportion of marijuana-positive drivers compared with the prelaw trend, alcohol-impaired driving remains a more prevalent threat to road safety in Arizona. Published by Elsevier B.V.
Entities:
Keywords:
Alcohol; Interrupted time series; Legalization; Medical marijuana; Motor vehicle crash
Authors: Mark Asbridge; Robert Mann; Michael D Cusimano; Cynthia Trayling; Michael Roerecke; John M Tallon; Alyce Whipp; Jürgen Rehm Journal: Int J Public Health Date: 2013-09-24 Impact factor: 3.380
Authors: Luke A Downey; Rebecca King; Katherine Papafotiou; Phillip Swann; Edward Ogden; Martin Boorman; Con Stough Journal: Accid Anal Prev Date: 2012-08-04
Authors: F Cittadini; N De Giovanni; L Caradonna; G Vetrugno; A Oliva; N Fucci; C Zuppi; V L Pascali; M Covino Journal: Eur Rev Med Pharmacol Sci Date: 2017-05 Impact factor: 3.507
Authors: Julian Santaella-Tenorio; Christine M Mauro; Melanie M Wall; June H Kim; Magdalena Cerdá; Katherine M Keyes; Deborah S Hasin; Sandro Galea; Silvia S Martins Journal: Am J Public Health Date: 2016-12-20 Impact factor: 9.308
Authors: Jeffrey R Brubacher; Herbert Chan; Walter Martz; William Schreiber; Mark Asbridge; Jeffrey Eppler; Adam Lund; Scott Macdonald; Olaf Drummer; Roy Purssell; Gary Andolfatto; Robert Mann; Rollin Brant Journal: BMJ Open Date: 2016-03-10 Impact factor: 2.692